Related by context. All words. (Click for frequent words.) 84 Erectile Function 72 IIEF 70 Female Sexual Function 66 Profile SEP 65 Ocular Surface Disease 64 OSDI 64 Crohn Disease Activity 62 Score IPSS 62 WOMAC 61 Sexual Encounter 61 erection hardness 60 NIH CPSI 60 International Prostate Symptom 60 HAMD 60 ADAS cog 59 Alzheimer Disease Assessment 59 WOMAC pain 59 YMRS 59 Disease Activity 59 IPSS 59 HRQoL 58 Main Outcome Measures 58 PANSS 58 ADCS CGIC 58 Prognostic Index 58 IRLS 58 Index FSFI 58 Montgomery Åsberg Depression 58 Global Impression CGI 58 ADAS Cog 57 Health Assessment Questionnaire 57 HRQL 57 Montgomery Asberg Depression 57 Index CDAI 57 Erectile 57 EQ 5D 57 PANSS total 57 Seattle Angina Questionnaire 57 PSQI 57 UPDRS motor 56 SELENA SLEDAI 56 Brief Psychiatric 56 Severity Index PASI 56 CFQ R 56 HAM D# 56 HDRS 56 Rating Scale IRLS 56 FSFI 56 Visual Analogue Scale VAS 56 Brief Pain 55 Scale Cognitive Subscale 55 Psoriasis Area 55 Rating Scale MADRS 55 EORTC QLQ C# 55 Functional Assessment 55 Severity Index 55 pain subscale 55 HAQ DI 55 Likert scale 55 SARAH BURNETT • 54 UPDRS 54 Severity MSCS score 54 Visual Analog Scale 54 Functioning GAF 54 Strategos wRatings Innovation 54 erectile function 54 SGRQ 54 QoL 54 GERD symptom 54 interrater reliability 54 QIDS SR 54 IBDQ 54 DLQI 54 Main Outcome Measure 54 ANCOVA 54 CDAI 54 HAM D 54 IELT 54 subscales 54 PANSS Positive 54 HRQOL 54 convergent validity 54 Neuropsychiatric Inventory 54 Pain Intensity 54 EF Domain 54 psychometric properties 54 State Examination MMSE 54 HOMA IR 54 BMI z 54 NYHA functional class 53 MarketLive Performance 53 CHADS2 53 MADRS 53 Primary endpoints 53 Inventory BPI 53 subscale scores 53 Rating Scale UPDRS 53 interrater 53 correlation coefficients 53 Secondary endpoints include 53 Hamilton Rating Scale 53 Distress Scale 53 Status Scale EDSS 53 Score DAS 53 Assessment Questionnaire 53 BILAG 53 SF #v# 53 fasting plasma 53 Scale EDSS score 53 Geriatric Depression 53 PCWP 53 Severity Scale 53 interobserver 53 Scale PANSS 53 Fibromyalgia Impact Questionnaire 53 Score TOS 53 IKDC 53 Rating Scale BPRS 53 logistic regression analyzes 53 posttreatment 53 Neuropsychiatric Inventory NPI 53 Glasgow Coma Scale 53 neurocognitive function 53 Traveler Sentiment 53 symptom severity 52 Univariate 52 HADS 52 intraclass correlation coefficient 52 PEPI 52 Foot Posture 52 Echocardiographic 52 Treatment Outcome 52 IQR 52 Risk Stratification 52 Scale EDSS 52 Kaplan Meier estimates 52 Unified Parkinson Disease 52 multiple logistic regression 52 albumin excretion rate 52 prospective multicentre 52 Stroke Scale 52 subscore 52 Expanded Disability Status 52 cardiac autonomic 52 retest reliability 52 Secondary endpoints included 52 CDAI score 52 DAS# CRP 52 Dyspnea 52 point Likert scale 52 Secondary endpoints 52 depressive symptom 52 nadroparin 52 QRS duration 52 waist circumference WC 52 Joshua Coman 52 Thrombolysis 52 Cronbach alpha 52 Y BOCS 52 Negative Syndrome 52 WAIS III 51 visceral adiposity 51 liver histology 51 Comorbidity 51 RECIST Response Evaluation Criteria 51 Bioavailability 51 Wechsler Adult 51 Depression Rating Scale 51 hematological parameters 51 Mean Symptom Complex 51 BPRS 51 Outcome Measures 51 Skin sterol 51 CIBIC + 51 ADCS ADL 51 Beck Anxiety Inventory 51 mean ± SEM 51 Symptom Checklist 51 Insulin sensitivity 51 spirometric 51 DQI 51 Ashworth Scale 51 ASA Staffing 51 Diagnostic Interview 51 ADHD Rating Scale 51 Coronary Artery Calcium 51 NIS LL 51 covariance 51 demonstrated clinically meaningful 51 ejaculatory function 51 Symptom severity 51 Histologic 51 left ventricular diastolic 51 Diseases Ninth 51 semiquantitative 51 Score DAS# 51 Sexual Satisfaction 51 subscores 51 confirmed CCyR 51 CombAT 51 Cystic Fibrosis Questionnaire Revised 51 Interactive Healthy Eating 51 Faculty Scholarly Productivity 51 Oswestry Disability Index 51 carotid IMT 51 TI Corruption Perceptions 51 Global Impression 51 HDI Customer Satisfaction 51 Numeric Rating Scale 51 prespecified secondary 50 Secondary efficacy endpoints 50 Outcomes Study 50 subjective sleepiness 50 Impressions Improvement 50 IRLS score 50 Abnormal Involuntary Movement 50 VFQ 50 Hamilton Anxiety Scale 50 exploratory endpoints 50 meta regression 50 DAS# scores 50 Myocardial Infarction TIMI 50 CIMZIA TM certolizumab pegol 50 Symptom Severity 50 Depression Inventory 50 Consumer Reports Trouble Tracker 50 Coronary calcium 50 PERMP 50 McMaster Universities Osteoarthritis 50 lopinavir r arm 50 APACHE II 50 fructosamine 50 Mania Rating Scale 50 ADHD RS 50 Diagnostic Interview CIDI 50 MMSE 50 CIBIC plus 50 oxygen desaturation 50 NIHSS 50 CNS LS 50 elevated ALT 50 intraobserver 50 Russell MicroCap 50 clinicopathological 50 MIKE HORTON • 50 nasal symptom 50 Persistent Sleep 50 QOL 50 anthropometric measures 50 coronary artery calcification 50 Insomnia Severity Index 50 Cardiorespiratory fitness 50 Continence Society 50 CRQ 50 SYNTAX 50 posttest 50 Symptom 50 WOMAC scores 50 ankle brachial 50 intact parathyroid hormone 50 Clinician Administered PTSD 50 actigraphy 50 adenotonsillectomy 50 echocardiographic parameters 50 estimated glomerular filtration 50 variance ANOVA 50 BPH symptom 49 Capacity FVC 49 DOLLAR INDEX Dollar 49 intraclass correlation coefficients 49 Depression Scale 49 DAS# [002] 49 STRIDE PD 49 Functioning Scale 49 sociodemographic characteristics 49 Subgroup analyzes 49 Stroke Scale NIHSS 49 SSRI citalopram 49 Descriptive statistics 49 MADRS score 49 JPMorgan Chase EMBI + 49 Injury Severity Score 49 Vitro Diagnostic Multivariate 49 Negative Symptoms 49 Shariah Hedge Fund 49 Prognostic 49 Charlson Comorbidity Index 49 baseline HbA1c 49 Anthropometric 49 LV ejection fraction 49 Histological 49 Fund FXI PriceWatch 49 left ventricular LV 49 ejaculatory control 49 serologically active patients 49 MSCI ESG 49 Mercent eCommerce Performance 49 hemoglobin A1c HbA1c 49 Entrex Private Company 49 Natural Catastrophe Stress 49 estimated GFR 49 Randomized Evaluation 49 Univariate analysis 49 CORE OM 49 EURIDIS 49 Fund AMEX SLX 49 psychosocial functioning 49 Headache Disorders 49 mg XP# 49 EquiTrend ® 49 Depressive Symptomatology 49 Integrated Pulmonary 49 Pain Rating Scale 49 DAS# remission 49 Questionnaire 49 Epworth Sleepiness Scale 49 = #.#-#.# 49 salivary cortisol 49 KOOS 49 secondary efficacy endpoint 49 Likert pain 49 PDSS 49 pulmonary capillary wedge 49 x ULN 49 Ejection Fraction 49 NIHSS score 49 function subscale 49 CSI Smallcap 49 Source Lipper 49 Psychiatric Epidemiology 49 DASI 49 Scale cognitive subscale 49 BMI waist circumference 49 GfK NOP Consumer Confidence 49 ancrod 49 MDRD 48 serum lipid 48 serum estradiol 48 lipid parameters 48 abdominal adiposity 48 aspartate aminotransferase AST 48 lactate dehydrogenase LDH 48 Likert 48 ACR# ACR# 48 bivariate 48 Zestra R 48 Functional Outcomes 48 Acute Physiology 48 State Exam MMSE 48 Endocrine Therapy 48 investable hedge fund 48 serum IGF 48 bivariate analysis 48 multivariate Cox 48 FDA defined valvulopathy 48 Hopkins Symptom Checklist 48 apnea hypopnea 48 intima media thickness 48 Depressive Symptoms 48 Randomized controlled 48 overnight polysomnography 48 â ‰ ¥ 48 Tasigna prolongs 48 6MWD 48 MMSE score 48 Major Adverse Cardiac 48 Coronary artery calcium 48 semistructured interviews 48 oxycodone CR 48 multicenter multinational 48 reactive hyperemia 48 Assessment Scale 48 somatostatin analog 48 Erectile function 48 prognostic variables 48 NASDAQ Dividend Achievers 48 APOE genotype 48 NPRS 48 ACTEMRA TM 48 Somnolence 48 PROactive study 48 -#.# mg dL [001] 48 Non inferiority 48 apnea hypopnea index 48 HBeAg negative patients 48 depressive symptomatology 48 #q# deletion syndrome 48 urinary albumin excretion 48 Likert scales 48 Neuroticism 48 Rosenberg Self Esteem 48 Bayley Scales 48 Endothelial function 48 Present Situations 48 Apgar scores 48 unpaired t 48 Healthy Behavior 48 insulin resistance HOMA IR 48 interquartile range IQR 48 Pearson correlation coefficient 48 vasomotor 48 covariate 48 eNO 48 Index HAQ DI 48 untreated psychosis 48 SLEDAI 48 Endothelial dysfunction 48 psychopathological symptoms 48 alteplase 48 diabetes mellitus DM 48 multivariate regression analysis 48 bronchial hyperresponsiveness 48 intravaginal ejaculatory latency 48 STRATEGY FOR AN OPEN 48 glycated hemoglobin 48 Complications Trial 48 Diseases ICD 48 Index CDAI score 48 Source LIMRA 48 System IPSS 48 ‰ ¥ 48 Pearson correlation coefficients 48 serum lipids 48 plasma renin activity 48 urinary sodium excretion 48 Psychometric 48 ALS Functional 48 nerve conduction velocity 48 fasting insulin 48 clinicopathologic 48 FACIT 48 HAQ 48 Reported Outcome 48 Supplemental Material 48 -#.# ± [002] 48 Depressive symptoms 48 % CI #.#-#.# [006] 48 leukocyte counts 48 hemodynamic measurements 48 glucose insulin 47 PANSS scores 47 Orthostatic Hypotension 47 activated partial thromboplastin 47 Test Methodology 47 retrospective observational study 47 Incontinence Impact Questionnaire 47 Structured Clinical 47 preoperatively 47 tissue oxygenation 47 trough FEV1 47 adiponectin concentrations 47 GH deficiency 47 Satisfaction Questionnaire 47 MetS 47 risk reducing salpingo 47 EMBLEM TM 47 Systems HCAHPS 47 SSRI SNRI 47 Rating Scale 47 Systemic Lupus Erythematosus 47 Visual Analog 47 Bipolar Disorders 47 HEDIS R 47 FEV ^ sub 47 ACR# response 47 subtest 47 CDR Counterparty Risk 47 anthropometric 47 CIBIC Plus 47 achieved statistical significance 47 epoetin alpha 47 UPDRS Part III 47 prospectively stratified 47 % Confidence Interval 47 logistic regression analysis 47 aminotransferase ALT 47 univariate 47 PIRLS 47 Joins Russell Microcap 47 P = .# 47 sociodemographic factors 47 Nocturia 47 neurobehavioral functioning 47 Scale CNS 47 clinico pathological 47 Autism Diagnostic 47 multicenter prospective 47 Urogenital Distress Inventory 47 luteinising hormone LH 47 Flesch Kincaid 47 quantitative coronary angiography 47 thickness CIMT 47 SCr 47 F FDG PET 47 desvenlafaxine succinate 47 univariate analyzes 47 hepatic lesions 47 Pharmacodynamic 47 Glycemic load 47 Eur Urol 47 PHQ 9 47 inflammatory biomarkers 47 virological response 47 trials RCTs 47 CR nPR 47 Solid Tumors 47 GPRD 47 comorbid anxiety 47 Polysomnography 47 ratio WHR 47 Forced Vital 47 International Prognostic Scoring 47 serum folate concentrations 47 Unity Wellbeing 47 SLE Responder Index 47 neurodevelopmental outcome 47 Mini Mental 47 glomerular filtration 47 multivariate logistic regression 47 urinary albumin 47 vitro diagnostic multivariate 47 guanfacine extended release 47 aminotransferase 47 electrophysiologic 47 serum lipid levels 47 affective psychosis 47 Luxury Customer Experience 47 PASI 47 STAI 47 Suboptimal 47 urinary N telopeptide 47 By MATT ANDERSON 47 reactogenicity 47 multivariate analyzes 47 DSM IV SCID 47 FOR AN OPEN 47 Randomized Controlled Trials 47 unadjusted Purchase 47 preoperative PSA 47 XIENCE V PROMUS Stent 47 plasma lipids 47 P Midcap Financials 47 Neurocognitive 47 emotional lability 47 BPS IC 47 postprocedure 47 Brazil Bovespa Stock 47 Consumer Credit Default 47 hemoglobin A1C 47 ascending aortic 47 lipid profiles 47 HbA 1c levels 47 Negative Symptom Scale 47 Wilcoxon rank sum 47 PsA 47 glycosylated hemoglobin HbA1c 47 fasting plasma glucose FPG 47 Effectiveness Data 47 mg QD 47 Pfizer reanalyzed 47 Edinburgh Postnatal Depression 47 QTc intervals 47 NNT = 47 mRS 47 Atomoxetine 46 Logistic regression 46 System NDIS 46 impaired glucose metabolism 46 genital arousal 46 SELENA SLEDAI score 46 HBeAg seroconversion 46 Multicenter 46 anogenital distance 46 Coleman Liau 46 OPTIMIZE 46 INVEGA ® 46 logistic regression 46 RT qPCR 46 prespecified 46 multiple linear regression 46 function subscales 46 Differential Diagnosis 46 Impaired fasting glucose 46 MSLT 46 Hemodynamic 46 cerebral oxygenation 46 rhinoconjunctivitis 46 multivariable analysis 46 sociodemographic 46 PREZISTA r arm 46 baseline serum creatinine 46 preintervention 46 DSM IV Axis 46 sd = 46 prednisone prednisolone plus 46 platelet reactivity 46 perioperatively 46 ACR Pedi 46 BENICAR 46 mg BID dose 46 Ischaemic 46 HbA1C 46 seropositivity 46 bortezomib refractory 46 weakly correlated 46 Pharmacokinetic parameters 46 Conscientiousness 46 enthesitis 46 plasma lipid 46 highest tertile 46 Hypoactive Sexual Desire Disorder 46 RE LY ® 46 Hemoglobin A1c 46 DEXA scan 46 overactive bladder symptoms 46 haematologic 46 Subgroup analysis 46 AUA Symptom Score 46 PLMS 46 iShares MSCI EMU 46 Glomerular Filtration Rate 46 Glomerular filtration rate 46 VKORC1 46 covariance ANCOVA 46 endometrial thickness 46 glycated hemoglobin HbA1c 46 CONCERTA ® 46 euthymic 46 Change PGIC 46 aspartate aminotransferase 46 analgesic efficacy 46 urodynamic parameters 46 Sexual Function 46 ONGLYZA saxagliptin 46 Self Efficacy 46 Noncritical 46 #:# -# [004] 46 -#.# mg dL [002] 46 mcg QD 46 Arch Neurol 46 Dyspepsia 46 Adult ADHD 46 -#.# log# copies mL 46 6MWT 46 premorbid 46 administered cetrorelix 46 tumor histology 46 immunohistochemical 46 oocytes retrieved 46 dyspnea 46 Electroencephalography 46 Prospective Randomized 46 binary logistic regression 46 postintervention 46 Malignant Lymphoma 46 FACIT Fatigue 46 ug dose 46 p = .# [002] 46 dyssynchrony 46 Preoperatively 46 zonisamide SR 46 A1c levels 46 attain statistical significance 46 coronary stenosis 46 Virologic Response 46 predictive validity 46 ECOG PS 46 ISE CCM Nanotechnology 46 Depression Inventory BDI 46 subthreshold depression 46 Chronic Illness Therapy 46 State Trait Anxiety 46 multivariable Cox 46 sociodemographic variables 46 bioavailable testosterone 46 Regression analyzes 46 Psychosomatic Research 46 total cholesterol HDL 46 atherosclerotic renal artery stenosis 46 Index WOMAC 46 Bonferroni correction 46 nmol l 46 Subjective 46 semistructured interview 46 HBsAg 46 cEVR 46 ERalpha 46 Common Terminology Criteria 46 Dividend Achievers TM 46 psychophysiological 46 metabolic parameters 46 Child Behavior Checklist 46 glycosylated hemoglobin levels 46 NCT# ClinicalTrials.gov 46 Finger Length 46 QT intervals 46 Cockcroft Gault 46 polysomnogram 46 Solid Tumours 46 erythrocyte sedimentation rate 46 ELISPOT 46 lowest tertile 46 Nonalcoholic Fatty Liver Disease 46 Clinical Relevance 46 number NCT# ClinicalTrials.gov 46 Mortality Risk 46 Prostate specific antigen 46 morphometric vertebral fractures 46 Kaplan Meier analysis 46 ANOVA 46 Intervention Trial 46 Quality Indicators 46 HbA1C levels 46 RE LY trial 46 alfuzosin 46 angiotensin II receptor blockers 46 pharmacodynamic parameters 46 leukocyte count 46 HH CAHPS 46 Multicentre 46 mg TID 46 Visit LIMRA 46 pulmonary arterial 46 Endothelial Function 46 symptomatic VTE 46 microsatellite instability 46 oral anticoagulation 46 Alzheimer Disease Cooperative 46 Sleep Disturbance 46 Arch Dermatol 46 thyroid peroxidase 46 lumbar spine BMD 46 total cholesterol triglycerides 46 -#.# log# 46 premenopause 46 Assigns LS 46 Ann Emerg Med 46 Myocardial 46 clinically meaningful improvements 46 antibody titer 45 Atopic Dermatitis 45 creatinine clearance 45 periprocedural 45 posttransplant 45 methacholine challenge 45 rotigotine 45 depressive symptoms 45 histologic 45 BEXXAR Therapeutic Regimen 45 odds ratios ORs 45 SVR# 45 interquartile range 45 Price Comparison 45 hsCRP levels 45 Postoperative 45 Left Ventricular 45 aminotransferase levels 45 Meta analyzes 45 Arch Intern Med 45 LH FSH 45 Cardiac Resynchronization 45 confidence intervals CIs 45 flow mediated dilation 45 REYATAZ r arm 45 euthymic patients 45 Visual Analogue Scale 45 hypogonadal men 45 Multicenter AIDS 45 CPAP adherence 45 Healthy Eating Index 45 serum phosphate 45 meta analytic 45 SIMPADICO 45 pretransplant 45 Quotient TM 45 fasting serum 45 Multiple logistic regression 45 5 HTTLPR 45 nonfasting 45 generalized anxiety disorder GAD 45 logistic regression models 45 achieved ACR# 45 DSM IV diagnoses 45 dyspnoea 45 serum ferritin 45 Clinicaltrials.gov 45 Visual acuity 45 transaminase 45 Logistic regression analysis 45 OGTT 45 Restless Legs 45 % CI #.#-#.# [008] 45 Patient Satisfaction 45 cognitive affective 45 alanine aminotransferase 45 MDRD equation 45 serum phosphorous 45 Bioequivalence 45 intima media thickness IMT 45 dehydroepiandrosterone sulfate 45 Ischemic Stroke 45 Acceptability 45 Bipolar Disorder STEP BD 45 baseline FEV 45 ASIA Impairment 45 Serum concentrations 45 UPDRS scores 45 Genant modified Sharp 45 Coronary Artery Bypass Graft 45 comorbidity 45 cells mcL 45 tipranavir r 45 FDG PET imaging 45 CAVEATS 45 serum aminotransferase levels 45 BARACLUDE r 45 Interpersonal Psychotherapy 45 Teriflunomide 45 metabolite concentrations 45 CI -#.# 45 Framingham Offspring 45 placebo controlled dose escalation 45 immunochemical fecal occult 45 explanatory variables 45 interobserver agreement 45 certolizumab 45 Genomic Grade 45 PLMs 45 Clinical Outcome 45 Governance Metrics 45 demographic variables 45 PROactive 45 histopathologic 45 Response Evaluation Criteria 45 multicentre prospective 45 tapentadol IR 45 Heart Rate Variability 45 transcranial Doppler ultrasound 45 Fecal Incontinence 45 HER2 expression 45 non menstrual pelvic 45 orthostatic 45 Poisson regression 45 ± SD 45 Myocardial Perfusion 45 4mg/kg 45 Arterial stiffness 45 Demonstrated Significant 45 HbA1c levels 45 subclinical atherosclerosis 45 Physical Component 45 carotid intima media 45 limiting generalizability 45 chi squared 45 Carotid Endarterectomy 45 Postoperatively 45 sociodemographics 45 Novel Compound 45 urodynamic 45 hematologic parameters 45 icatibant 45 transient elastography 45 elevated transaminases 45 multicenter randomized controlled 45 psychosocial variables 45 BANG Media 45 autonomic dysfunction 45 Neuropsychological 45 Medication Adherence 45 cTnT levels 45 Duration 45 ARB telmisartan 45 unfractionated heparin UFH 45 Anxiety Depression 45 hepatic enzyme 45 akinesia 45 interobserver reliability 45 EDSS scores 45 somatization 45 clinically meaningful improvement 45 subtests 45 glomerular filtration rate 45 bronchoalveolar lavage fluid 45 antiretroviral naive 45 colesevelam 45 plasma adiponectin 45 PaO 2 45 rs# [002] 45 tapentadol ER 45 Physical Function 45 weekly CSBMs 45 biopsy Gleason 45 Laryngeal Cancer 45 Fasting plasma glucose 45 cytoreductive nephrectomy 45 Cystatin C 45 nonmetastatic 45 nondiabetic patients 45 urine albumin 45 serum concentrations 45 Subgroup Analysis 45 acoustic startle 45 prospectively defined 45 alicaforsen enema 45 nonobese 45 categorical variables 45 endoscopic remission 45 Sterilization Supplies Markets Independently 45 PEGylated anti 45 plasma leptin 45 creatinine ratio 45 MMSE scores 45 OHQ 45 immunohistochemical analysis 45 Initiated Phase 45 antiretroviral naïve 45 abdominal pain abdominal discomfort 45 ARIXTRA 45 methotrexate monotherapy 45 Oral Glucose Tolerance 45 BILAG B 45 Operative mortality 45 kg m² 45 Cronbach 45 Adalimumab 45 statistically significant correlation 45 Multivariate logistic regression 45 Pharmacogenetic 45 EBMT criteria 45 apolipoprotein B 45 FluCAM arm 45 Charlson comorbidity index 45 TLUS 45 Nutritional Status 45 Platelet Function 45 brachial artery flow 45 CCyR 45 hours postdose 45 systolic function 45 fasting plasma glucose 45 CAHPS R 45 NCT# 45 MAXALT 45 bivalirudin monotherapy 45 neuropsychological assessment 45 alexithymia 45 LDL triglycerides 44 Clinical Psychopharmacology 44 Warfarin Coumadin 44 Unimer Research 44 rFSH 44 prasterone 44 predefined criteria 44 thyrotropin 44 dactylitis 44 electroencephalographic 44 EPDS 44 NATRECOR ® 44 β blockers 44 dose proportionality 44 plus COPEGUS 44 recurrent venous thromboembolism 44 cardio respiratory fitness 44 oral prednisolone 44 QTcF 44 exhaled NO 44 ST Segment Elevation 44 logistic regression model 44 Dividend Achievers Index 44 Psychiatry Res 44 adenoma recurrence 44 Epidemiologic Studies Depression 44 Intraocular pressure 44 spontaneous bowel movements 44 GERD migraine headaches 44 Text Revision 44 Restless Legs Syndrome 44 TNSS 44 regression coefficient 44 Methodological 44 Socioeconomic status 44 tonsillar hypertrophy 44 CIMZIA ™ 44 noncognitive 44 CaPSURE 44 beta blocker therapy 44 dexamethasone suppression 44 Mantel Haenszel 44 phosphodiesterase inhibitors 44 serum bilirubin 44 IndexTM 44 sleep onset WASO 44 pharmacokinetics PK 44 Cerebrovascular Diseases 44 Quantile 44 CANCIDAS 44 neurocognitive functioning 44 IL#B genotype 44 glycated hemoglobin levels